Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
Status:
Terminated
Trial end date:
2019-04-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if postoperative chemotherapy in patients with
high-grade appendix cancer after surgery improves outcomes.
The postoperative chemotherapy will consist of 5-FU (with leucovorin) or capecitabine with
bevacizumab. These drugs are approved for use in people with colon cancer, and they are used
at UCSD for some patients with appendix cancer.
The purpose of this study is to explore the safety and efficacy of the postoperative
chemotherapy treatment on cancer.